👋This is Mohammad Jad, Postdoc. Fellow & Postdoc. Association Team Leader @MDAndersonNews, mentored by @DocMattCampbell & @OAlhalabiMD
👉Applying for #InternalMedicine Residency #Match2025
🙏Dreaming of becoming a humane #oncologist through purposeful science – excited to find the right #IM program to make this dream a reality!
AAMC ID: 15705243 #IMG
Hi #MedTwitter !
I'm Lynn Bitar, a postdoc research fellow at @UTSWMedCenter & @childrens, from @USJLiban 🇱🇧.
Excited to be applying for #Pediatrics#Match2025.
I am passionate about neonatal brain🧠, sports🏊🏼♀️🎾, and child advocacy.
Let's connect!
AAMC ID: 16045376
Hello #MedX! I'm Hadi Younes, a postdoc research fellow at @TulaneTriad.
Excited to apply for #InternalMedicine#Match2025!
My work focuses on medical education, AI in Healthcare, and patient advocacy.
Looking forward to connecting with programs and peers!
Does congenital 🫀disease affect neonatal 🧠 development?
Insights about placental vascular malperfusion and cerebral artery resistive indices
Link: https://t.co/KdCCzZiAem
🌟Introducing Pixelier! 🚀 Transform your cherished memories into stunning postcards and posters with a magical twist. Pixelier brings your favourite moments to life through Augmented Reality.
Available on the App Store https://t.co/3d8aTKLNsY
#pixelier#AugmentedReality
Recent retrospective study by Deharo et al comparing MVR vs TEER for Mitral Regurgitation in the French Registry. Higher CV mort in MVR and higher non CV mortality in the TEER. No difference in mortality….(1/n) @ehj_ed
Check out our new publication in @JournalofCF on preventive service utilization in #cysticfibrosis patients! 🫁🤓🎉
I’m immensely grateful to my mentor @susanli0888 and all other co-authors for the opportunity.
@CF_Foundation https://t.co/PzPFR2z2oy
Brilliant news!! Still no recurrence of my supposedly incurable #glioblastoma!! Median time 2 recurrence 4 all pts is 6 months; I’m now out to 8 months! Perhaps neoadjuv/adjuv combi immunotherapy is effective?? Need clinical trial. Thx family, @ProfGLongMIA & diverse whole team!
#CardioTwitter
- 4012 patients with subclinical a fib lasting 6 min to 24 hours.
-36.1% female
-Randomized to apixaban or aspirin 81 mg
-Mean f/up of 3.5±1.8 y
- Apixaban⏭️ ⬇️risk of stroke or systemic embolism but a⬆️ risk of major bleeding.
@NEJM@RichardAFerraro
🚨Another step forward in understanding the 🔁 link between #Afib & #HF
Up to 50% of HF pts acquire AF
🤔Why?
👉Secondary resp to pathophysiological consequences of HF on atria
🆕Primary genomic response of atrial myocardium❗️
🖇️https://t.co/H5DsiVIaK9
@CircAHA@AHAScience